amlodipine has been researched along with lisinopril in 177 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (11.30) | 18.2507 |
| 2000's | 72 (40.68) | 29.6817 |
| 2010's | 73 (41.24) | 24.3611 |
| 2020's | 12 (6.78) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Patel, VB; Preedy, VR; Richardson, PJ; Siddiq, T | 1 |
| Fogari, R; Malamani, GD; Marasi, G; Vanasia, A; Villa, G; Zoppi, A | 1 |
| Patel, VB; Preedy, VR; Richardson, PJ; Why, HJ | 1 |
| Blankestijn, PJ; Floor, M; Hené, RJ; Koomans, HA; van der Schaaf, MR | 1 |
| Andriani, A; De Cesaris, R; Lamontanara, G; Ranieri, G | 1 |
| Marway, JS; Paice, AG; Patel, VB; Preedy, VR; Richardson, PJ; Siddiq, T | 1 |
| Cappuccio, FP; MacGregor, GA; Markandu, ND; Singer, DR | 1 |
| Amery, A; Staessen, J | 1 |
| August, P; Laragh, JH; Lenz, T | 1 |
| Lund-Johansen, P; Omvik, P | 1 |
| Antonios, TF; Cappuccio, FP; MacGregor, GA; Markandu, ND; Sagnella, GA | 1 |
| Beltman, FW; de Graeff, PA; Havinga, TK; Heesen, WF; Kok, RH; Lie, KI; May, JF; Meyboom-de Jong, B; Schuurman, FH; Smit, AJ; van der Veur, E | 1 |
| Arosio, E; Lechi, A; Minuz, P; Pancera, P; Pirante, F; Ribul, M | 1 |
| D'Hondt, A; Depierreux, M; Hanson, B; Lustman, F | 1 |
| Beltman, FW; de Graeff, PA; Havinga, TK; Heesen, WF; Lie, KI; May, JF; Meyboom-de Jong, B; Schuurman, FH; Smit, AJ; van der Veur, E | 1 |
| Fowler, G; Lorimer, AR; Lyons, D; Petrie, JC; Rothman, MT | 1 |
| Gans, RO; Janssen, JJ; Pijpers, R; ter Wee, PM; van der Meulen, J | 1 |
| Imai, Y; Ohkubo, T; Omae, T; Sekino, M | 1 |
| Beltman, F; de Graeff, P; Havinga, T; Heesen, W; Lie, K; May, J; Meyboom-de Jong, B; Schuurman, F; Smit, A; van der Veur, E | 1 |
| Hilleman, DE; Mohiuddin, SM; Ryschon, KL; Wurdeman, RL | 1 |
| Naidu, MU; Rao, TR; Shobha, JC; Usha, PR | 1 |
| Ahmed, S; MacNee, W; Mantle, D; Patel, VB; Preedy, VR; Rahman, I; Richardson, PJ; Wassif, WS; Why, HJ | 1 |
| Schillaci, G; Verdecchia, P | 1 |
| Crijns, HJ; de Graeff, PA; Havinga, TK; May, JF; Meyboom-de Jong, B; Schuurman, FH; Smit, AJ; Terpstra, WF; van den Veur, E | 1 |
| Barzilay, JI; Basile, JN; Ciocon, JO; Davis, BR; Goff, DC; Jones, CL; Randall, OS; Sweeney, ME | 1 |
| Chapman, JN; Hughes, AD; Mayet, J; Poulter, NR; Sever, PS; Stanton, AV; Thom, SA | 1 |
| Nathisuwan, S; Talbert, RL | 1 |
| Brown, MJ; Deary, AJ; Foo, RS; Haydock, SF; Murfet, H; Schumann, AL | 1 |
| Düsing, R | 2 |
| Nilsson, P | 1 |
| Berglund, G; Håkansson, J; Hernborg, A; Werkö, L | 1 |
| Traynor, K | 1 |
| Wepner, U | 1 |
| Vidt, DG | 1 |
| Vetter, W | 1 |
| Slany, J | 1 |
| Rollins, G | 1 |
| Scott, I; Stowasser, M | 1 |
| Siragy, HM | 1 |
| Messerli, FH; Weber, MA | 1 |
| Ferdinand, KC | 1 |
| Rahn, KH | 1 |
| Chiang, HT; Lin, SL; Liu, CP; Wu, SC | 1 |
| Alexander, GJ; Brown, MJ; Byrne, CD; Neal, DA; Wilkinson, IB | 1 |
| Kuwajima, I | 1 |
| Crijns, HJ; Graeff, PA; May, JF; Meyboom-de Jong, B; Smit, AJ; Terpstra, WF | 1 |
| Leenen, FH | 1 |
| Alekseenko, SA; Avilova, AA; Fleĭshman, MIu; Lamekhova, VG; Timoshin, SS | 1 |
| Cushman, WC; Cutler, JA; Davis, BR; Dunn, JK; Ford, CE; Habib, GB; Haywood, LJ; Leenen, FH; Margolis, KL; Papademetriou, V; Probstfield, JL; Whelton, PK; Wright, JT | 1 |
| Barzilay, J; Batuman, V; Davis, BR; Eckfeldt, JH; Farber, M; Henriquez, M; Kopyt, N; Louis, GT; Nwachuku, C; Pressel, S; Rahman, M; Saklayen, M; Stanford, C; Walworth, C; Ward, H; Whelton, PK; Wiegmann, T; Wright, JT | 1 |
| Arnett, DK; Black, H; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Leiendecker-Foster, C; Miller, MB | 2 |
| Barzilay, J; Cushman, WC; Davis, BR; Iiamathi, E; Kostis, JB; Leenen, FH; Louis, GT; Margolis, KL; Mathis, DE; Moloo, J; Nwachuku, C; Panebianco, D; Parish, DC; Pressel, S; Simmons, DL; Thadani, U; Whelton, PK | 1 |
| Arslanagic, A; Bajraktarevic, A; Zulic, I | 1 |
| Barzilay, J; Batuman, V; Davis, BR; Eckfeldt, JH; Farber, MA; Franklin, S; Henriquez, M; Kopyt, N; Louis, GT; Nwachuku, C; Pressel, S; Rahman, M; Saklayen, M; Stanford, C; Walworth, C; Ward, H; Whelton, PK; Wiegmann, T; Wright, JT | 1 |
| Hollenberg, NK | 1 |
| Colon, P; Crow, R; Cutler, JA; Davis, BR; Dunn, K; Ellsworth, A; Franklin, S; Furberg, C; Goff, D; Golden, J; Leenen, F; Mohiuddin, S; Papademetriou, V; Piller, LB; Proschan, M | 1 |
| Alderman, MH; Atlas, SA; Basile, JN; Black, HR; Cushman, WC; Cuyjet, AB; Dart, R; Davis, BR; Felicetta, JV; Grimm, RH; Haywood, LJ; Jafri, SZ; Leenen, FH; Nwachuku, CE; Proschan, MA; Simpson, LM; Thadani, U; Whelton, PK; Wright, JT | 1 |
| Davidovich, IM; Petrichko, TA | 1 |
| Messerli, FH; Staessen, JA | 1 |
| Black, HR; Davis, BR; Ford, CE; Nwachuku, C; Oparil, S; Piller, LB; Probstfield, JL; Retta, TM | 1 |
| Juhász, M; Katona, E; Páll, D; Paragh, G | 1 |
| Barzilay, JI; Basile, J; Cutler, JA; Davis, BR; Margolis, KL; Ong, ST; Pressel, SL; Sadler, LS; Summerson, J; Whelton, PK | 1 |
| Black, HR; Cushman, WC; Davis, BR; Einhorn, PT; Levy, D; Massie, BM; Nwachuku, CE; Piller, LB; Simpson, LM | 1 |
| Chiang, YT; Fomina, I; Gamboa, R; Glazes, R; Kaczor, J; Kargiannis, S; Poldermans, D; Wernsing, M; Yen, J | 1 |
| Scarpello, JH; Tahrani, AA; Varughese, GI | 1 |
| Christian, R; Colon, PJ; Cushman, WC; Einhorn, PT; Ford, CE; Goff, DC; Henriquez, MA; Margolis, KL; Piller, LB; Vidt, DG; Wong, ND; Wright, JT | 1 |
| Baimbridge, C; Barzilay, J; Basile, J; Black, HR; Dart, RA; Davis, B; Marginean, H; Nwachuku, C; Thadani, U; Whelton, P; Wong, ND; Wright, JT | 1 |
| Arslanagić, A; Bajraktarević, A | 1 |
| Arnett, DK; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Leiendecker-Foster, C; Lynch, AI | 3 |
| Baimbridge, C; Bareis, CJ; Barzilay, J; Basile, JN; Black, HR; Dart, R; Davis, BR; Einhorn, PT; Gupta, AK; Hamilton, BP; Harris-Haywood, S; Haywood, LJ; Jafri, SZ; Louis, GT; Pressel, S; Scott, CL; Simmons, DL; Stanford, C; Whelton, PK; Wright, JT | 1 |
| Cutler, JA; Davis, BR; Furberg, CD; Goldman, L; Heidenreich, PA; Lairson, DR; Nwachuku, C; Pressel, SL; Shlipak, MG | 1 |
| Makarova, SV; Praskurnichiĭ, EA; Savel'eva, SA; Shevchenko, OP; Zhukova, VA | 1 |
| Praskurnichiĭ, EA; Savel'eva, SA; Shevchenko, OP | 1 |
| Chapman, N; Hughes, AD; Jabbar, AS; Martinez-Perez, ME; McG Thom, SA; Stanton, AV | 1 |
| Kékes, E | 1 |
| Kuzmanić, M; Pavlicević, I; Rumboldt, M; Rumboldt, Z | 1 |
| Basile, JN; Bastien, A; Courtney, DL; Cushman, WC; Davis, BR; Einhorn, PT; Ford, CE; Hamilton, BP; Kirchner, K; Louis, GT; Preston, RA; Retta, TM; Vidt, DG; Weiss, RJ; Whelton, PK; Wright, JT | 1 |
| Albert, DH; Banfor, PN; Cox, BF; Davidsen, SK; Franklin, PH; Fryer, RM; Gintant, GA; Larson, KJ; Noonan, WT; Segreti, JA; Tapang, P; Widomski, DL | 1 |
| de Leeuw, PW; Kessels, AG; Kroon, AA; Neef, C; van der Kuy, PH; van Onzenoort, HA; Verberk, WJ | 1 |
| de Leeuw, PW; Kessels, AG; Kroon, AA; Neef, C; Nelemans, PJ; van der Kuy, PH; van Onzenoort, HA; Verberk, WJ | 1 |
| Bek, T; Erlandsen, M; Jeppesen, P; Mehlsen, J; Poulsen, PL | 1 |
| Cohen, CD; Gaspert, A; Schorn, R | 1 |
| Arnett, DK; Barzilay, JI; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Irvin, MR; Kabagambe, EK; Lynch, AI; Tiwari, HK | 1 |
| Ariff, BB; Crowe, L; Firmin, DN; Glor, FP; Hughes, AD; Thom, SM; Vennart, W; Xu, XY | 1 |
| Comi-Diaz, C; Macias-Batista, A; Martinez-Martin, FJ; Pedrianes-Martin, P; Rodriguez-Rosas, H; Soriano-Perera, P | 1 |
| Buyukhatipoglu, H; Kilisli, H; Sayiner, ZA; Tiryaki, O; Usalan, C | 1 |
| Alderman, MH; Calhoun, DA; Cushman, WC; Davis, BR; Eckfeldt, JH; Einhorn, PT; Ford, CE; Franklin, SS; Furberg, CD; Ong, ST; Oparil, S; Papademetriou, V; Piller, LB; Probstfield, JL | 1 |
| Arnett, DK; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Leiendecker-Foster, C; Lynch, AI; Zhang, X | 1 |
| Baimbridge, C; Barzilay, JI; Brown, CD; Colon, PJ; Cutler, JA; Davis, BR; Fine, LJ; Ford, CE; Grimm, RH; Gupta, AK; Haywood, LJ; Henriquez, MA; Ilamaythi, E; Oparil, S; Piller, LB; Preston, R; Rahman, M; Whelton, PK; Wright, JT | 1 |
| Sowers, JR; Whaley-Connell, A | 1 |
| Bakhshaliev, AB; Gabieva, NN | 1 |
| Rölfing, JH | 1 |
| Alderman, MH; Blumenthal, SS; Castaldo, RS; Cushman, WC; Cutler, JA; Davis, BR; Ford, CE; Franklin, SS; Furberg, CD; Gordon, D; Graumlich, JF; Pavlik, V; Preston, RA; Proschan, M | 1 |
| Afanas'ev, IuI; Grigorova, SIu; Storozhenko, SIu | 1 |
| Gillessen, S; Rothermundt, C | 1 |
| Cushman, WC; Davis, BR; Ford, CE; Furberg, CD; Habib, GB; Haywood, LJ; Margolis, K; Oparil, S; Probstfield, JL; Whelton, PK; Wright, JT | 1 |
| Abrams, DC; Bacchetta, M; Bouchard, NC; Brodie, D; Burkart, KM; Dzierba, AL; Weinberg, RL | 1 |
| Bondarev, AM; Derevianchenko, MV; Ostrovskiĭ, OV; Shvets, MK; Statsenko, ME; Titarenko, MN | 1 |
| Alderman, MH; Davis, BR; Einhorn, PT; Ford, CE; Furberg, CD; Grimm, RH; Jafri, SZ; Oparil, S; Phillips, W; Piller, LB; Probstfield, JL; Whittle, J; Williamson, JD | 1 |
| Handler, J | 1 |
| Derevianchenko, MV; Mihaleva, AV; Statsenko, ME; Titarenko, MN | 1 |
| Jeffers, BW; Wang, JG; Yan, P | 1 |
| Davis, BR; Kostis, JB; Levitan, EB; Lynch, AI; Muntner, P; Oparil, S; Simpson, LM; Whelton, PK; Whittle, J | 1 |
| Barzilay, JI; Dart, RA; Davis, BR; Einhorn, PT; Graves, JW; Pressel, SL; Reisin, E; Retta, TM; Saklayen, MG; Yamal, JM | 1 |
| Baraniuk, S; Basile, JN; Dart, RA; Davis, BR; Ellsworth, AJ; Fendley, H; Habib, GB; Piller, LB; Probstfield, JL; Rahman, M; Simpson, LM; Whelton, PK | 1 |
| Avakian, AA; Glezer, MG; Prokof'eva, EB; Vygodin, VA | 1 |
| Arnett, DK; Boerwinkle, E; Davis, BR; Eckfeldt, JH; Ford, CE; Irvin, MR; Sørensen, IF; Sørensen, P; Vazquez, AI | 1 |
| Derevianchenko, MV; Statsenko, ME | 1 |
| Alderman, MH; Calhoun, DA; Cushman, WC; Davis, BR; Fendley, HF; Franklin, SS; Habib, GB; Oparil, S; Pressel, SL; Probstfield, JL; Sastrasinh, S; Yamal, JM | 1 |
| Galeeva, ZM; Galiavich, AS | 1 |
| Bogomaz, AV; Kobalava, ZhD; Kotovskaia, IuV; Semagina, IM | 1 |
| Kapoian, T; Ravella, S; Sherman, RA | 1 |
| Derevianchenko, MV; Pastukhova, OR; Statsenko, ME | 1 |
| Amjad-Iranagh, S; Goharpey, F; Modarress, H; Yousefpour, A | 2 |
| Glezer, MG; Prokofieva, EB | 1 |
| Abesadze, IT; Alugishvili, MZ; Basyrova, IR; Dyplyakov, DV; Hohlunov, SM; Isayeva, EN; Korzenewskaya, KV; Kryukov, AV; Kuleshova, EV; Libis, RA; Lohovinina, NL; Panov, AV; Safonova, DV; Titenkov, IV | 1 |
| Ferenci, T; Simonyi, G | 1 |
| Derevyanchenko, MV; Statsenko, ME | 1 |
| Chong, SJ; Howard, KA; Knox, C | 1 |
| Davis, BR; Lynch, AI; Muntner, P; Oparil, S; Rahman, M; Simpson, LM; Tanner, RM; Whelton, PK; Whittle, J | 1 |
| Albert, CM; Alonso, A; Davis, BR; Dewland, TA; Haywood, LJ; Magnani, JW; Marcus, GM; Piller, LB; Soliman, EZ; Yamal, JM | 1 |
| Beard, BL; Davis, BR; Ford, CE; Hamilton, BP; Marginean, H; Probstfield, JL; Suhan, PS; Whittle, J; Williamson, JD; Yamal, JM | 1 |
| Barzilay, JI; Cushman, WC; Davis, BR; Einhorn, PT; Ghosh, A; Louis, GT; Margolis, KL; Oparil, S; Pressel, SL; Puttnam, R; Whelton, PK; Williamson, J | 1 |
| Cushman, WC; Davis, BR; Einhorn, PT; Ernst, ME; Ghosh, A; Grimm, RH; Okin, PM; Oparil, S; Prineas, RJ; Soliman, EZ | 1 |
| Bangalore, S; Black, HR; Calhoun, DA; Cushman, WC; Davis, BR; Kostis, JB; Muntner, PM; Pressel, SL; Probstfield, JL; Rahman, M; Whelton, PK | 1 |
| Kochetkov, AI; Ostroumova, OD | 1 |
| Gridina, SA; Povetkin, SV | 1 |
| Bang, CN; Davis, BR; Devereux, RB; Okin, PM; Simpson, LM; Soliman, EZ | 1 |
| Coifman, RR; Coppi, AC; Davis, BR; Dhruva, SS; Furberg, CD; Huang, C; Krumholz, HM; Li, SX; Lin, H; Pressel, SL; Spatz, ES; Warner, F; Xu, X | 1 |
| Albert, CM; Alonso, A; Davis, BR; Dewland, TA; Haywood, LJ; Marcus, GM; Simpson, LM; Soliman, EZ; Yamal, JM | 1 |
| Semenova, AE; Sergienko, IV | 1 |
| Cheriyan, J; Chowienczyk, PJ; Cockcroft, JR; Collier, D; Coulson, JM; Dasgupta, I; Faconti, L; Glover, M; Heagerty, AM; Khong, TK; Lip, GYH; Mander, AP; Marchong, MN; Martin, U; McDonnell, BJ; McEniery, CM; Mukhtar, O; Padmanabhan, S; Saxena, M; Sever, PJ; Shiel, JI; Wilkinson, IB; Wych, J | 1 |
| Davis, BR; Einhorn, PT; Ford, CE; Ghosh, A; Haywood, LJ; Piller, LB; Probstfield, JL; Simpson, LM; Soliman, EZ; Wright, JT | 1 |
| Ekman, I; Lind, L; Lytsy, P; Marttala, K; Nowrouzi, S; Öhagen, P; Östlund, O; Sundström, J | 1 |
| Abrams, RI; Baxi, PV; Herring, MJ; Korbet, SM; Lichtenstein, SJ | 1 |
| Alhnan, MA; Dores, F; Forbes, RT; Habashy, R; Isreb, A; Oga, EF; Pereira, BC; Petit, JB | 1 |
| Arnett, DK; Barzilay, JI; Davis, BR; Lai, D; Pressel, S; Previn, HE | 1 |
| Bell, CS; Green, C; Molony, D; Pedroza, C; Samuel, JP; Samuels, J; Tyson, JE | 1 |
| Davis, BR; Johnson, K; Oparil, S; Tereshchenko, LG | 1 |
| Ansheles, AA; Boytsov, SA; Drapkina, ОМ; Gornyakova, NB; Kuharchuk, VV; Sergienko, IV; Shepel, RN; Zubareva, MY | 1 |
| Hebibovic, S; Jatic, Z; Rustempasic, E; Skopljak, A; Sukalo, A; Valjevac, A | 1 |
| Adedoyin, RA; Anchala, R; Balabanova, D; De Andrade, L; Kaur, H; Ofori, S; Redfern, J; Sani, MU; Vamadevan, AS; Zelaya, J | 1 |
| Kim, E; Morgenthau, A | 1 |
| Angkodjojo, S; Tan, PH; Yee, Y | 1 |
| Beach, JL; Davis, BR; Ishak, A; Juraschek, SP; Mukamal, KJ; Shmerling, RH; Simpson, LM | 1 |
| Basit, AW; Gaisford, S; Goyanes, A; Rowland, M; Tan, HX; Trenfield, SJ; Wilsdon, D | 1 |
| Glick, A; Johnson, C; Sista, V | 1 |
| Agarkov, NM; Kolomiets, VI; Korneeva, SI; Markelova, AM; Markelova, EA; Moskalev, AA; Moskaleva, EO; Okhotnikov, OI | 1 |
| Chang, TI; Itoga, NK; Montez-Rath, ME; Tawfik, DS | 1 |
| Bettencourt, JL; Davis, BR; Du, XL; Simpson, LM; Tandy, BC | 1 |
| Cao, Y; Gao, XM; Jiang, X; Li, T; Liu, SQ; Liu, YP; Ma, YP; Shi, P; Tao, Y | 1 |
| Gongal, P; Hanna, JM; Nanna, MG; Onuma, OK; Wang, SY | 1 |
| Ankrah, D; Hollingworth, SA; Okeke, CC; Ruiz, F; Thacher, E; Uzochukwu, BSC | 1 |
| Babinets, LS; Halabitska, IM; Kryskiv, OI; Levchuk, RD | 1 |
| Hagström, E; Held, C; Lind, L; Lytsy, P; Marttala, K; Neal, B; Nowrouzi, S; Östlund, O; Sundström, J | 1 |
| Tchernev, G | 1 |
10 review(s) available for amlodipine and lisinopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluation.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Drug Combinations; Humans; Hypertension; Lisinopril; Treatment Outcome; Verapamil | 1999 |
A review of vasopeptidase inhibitors: a new modality in the treatment of hypertension and chronic heart failure.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Dose-Response Relationship, Drug; Heart Failure; Humans; Hypertension; Lisinopril; Mesylates; Natriuretic Peptide, Brain; Neprilysin; Pyridines; Randomized Controlled Trials as Topic; Thiazepines; Tyrosine | 2002 |
Recommendations for the management of special populations: racial and ethnic populations.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Calcium Channel Blockers; Chlorthalidone; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Ramipril; Randomized Controlled Trials as Topic | 2003 |
[Recent intervention studies with antihypertensive drugs and their influence on guidelines].
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Clinical Trials as Topic; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Lisinopril; Meta-Analysis as Topic; Middle Aged; Myocardial Infarction; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic; Risk; Risk Factors; Sodium Chloride Symporter Inhibitors; Stroke; Time Factors | 2003 |
[ALLHAT trial--antithesis to the overuse of vasodilating antihypertensive drugs].
Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Double-Blind Method; Doxazosin; Humans; Hypertension; Lisinopril; Male; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Stroke | 2004 |
Amlodipine better than lisinopril? How one randomized clinical trial ended fallacies from observational studies.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Coronary Disease; Humans; Hypertension; Lisinopril; Randomized Controlled Trials as Topic | 2006 |
[Prevention of target organ damage with modern antihypertensive agents].
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Humans; Hungary; Hypertension; Lisinopril; Multicenter Studies as Topic; Patient Compliance; Risk Reduction Behavior | 2006 |
[Combined antihypertensive and antilipemic therapy as one of the pillars in the poly-pharmacologic preventive strategy for patients with high cardiovascular risk].
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atorvastatin; Biomarkers; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hungary; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Lisinopril; Male; Metabolic Syndrome; Middle Aged; Prevalence; Pyrroles; Risk Factors | 2008 |
Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Enalapril; Humans; Hypertension; Lisinopril; Losartan; Randomized Controlled Trials as Topic | 2014 |
87 trial(s) available for amlodipine and lisinopril
| Article | Year |
|---|---|
Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Fibrinogen; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Potassium; Triglycerides; Uric Acid | 1995 |
Hypertension after renal transplantation. Calcium channel or converting enzyme blockade?
Topics: Adult; Amlodipine; Blood Pressure; Cross-Over Studies; Cyclosporine; Double-Blind Method; Humans; Hypertension; Kidney; Kidney Transplantation; Lisinopril; Middle Aged | 1995 |
Effects of lisinopril and amlodipine on microalbuminuria and renal function in patients with hypertension.
Topics: Adult; Aged; Albuminuria; Amlodipine; Female; Hemodynamics; Humans; Hypertension; Kidney; Lisinopril; Male; Middle Aged | 1994 |
Amlodipine and lisinopril in combination for the treatment of essential hypertension: efficacy and predictors of response.
Topics: Adult; Amlodipine; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Forecasting; Hormones; Humans; Hypertension; Lisinopril; Male; Middle Aged; Supine Position; Time Factors | 1993 |
APTH--a trial on ambulatory blood pressure monitoring and treatment of hypertension: objectives and protocol.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure Determination; Blood Pressure Monitors; Dipeptides; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Research Design; Time Factors | 1993 |
A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril.
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Treatment Failure | 1996 |
Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients.
Topics: 6-Ketoprostaglandin F1 alpha; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cyclooxygenase Inhibitors; Epoprostenol; Heart Function Tests; Heart Rate; Humans; Hypertension; Ibuprofen; Lisinopril; Male; Middle Aged; Prostaglandins; Thromboxane A2; Thromboxane B2; Vasodilator Agents | 1996 |
Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Female; Heart Ventricles; Humans; Hypertension; Lisinopril; Male; Middle Aged | 1998 |
Differences between amlodipine and lisinopril in control of clinic and twenty-four hour ambulatory blood pressures.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Cross-Over Studies; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Single-Blind Method; Treatment Outcome | 1998 |
Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: a double-blind, randomized prospective study.
Topics: Adolescent; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Double-Blind Method; Female; Humans; Lisinopril; Male; Middle Aged; Prospective Studies; Proteinuria; Renal Insufficiency | 1998 |
Two-year follow-up study to evaluate the reduction of left ventricular mass and diastolic function in mild to moderate diastolic hypertensive patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diastole; Double-Blind Method; Echocardiography, Doppler, Pulsed; Female; Follow-Up Studies; Heart Ventricles; Humans; Hypertension; Lisinopril; Male; Middle Aged; Prospective Studies; Treatment Outcome | 1998 |
Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Cardiovascular Diseases; Chlorthalidone; Diuretics; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Survival Analysis | 2000 |
Evaluation of amlodipine, lisinopril, and a combination in the treatment of essential hypertension.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged | 2000 |
Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diastole; Double-Blind Method; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Middle Aged | 2001 |
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cholesterol, Dietary; Cohort Studies; Coronary Disease; Double-Blind Method; Doxazosin; Ethnicity; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Pravastatin; Racial Groups; Risk Factors; United States | 2001 |
Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Analysis of Variance; Antihypertensive Agents; Carotid Artery, Common; Confidence Intervals; Double-Blind Method; Female; Femoral Artery; Humans; Hypertension; Image Processing, Computer-Assisted; Lisinopril; Male; Middle Aged; Regression Analysis; Tunica Intima; Ultrasonography | 2001 |
Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bendroflumethiazide; Bisoprolol; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lisinopril; Male; Middle Aged; Natriuretic Peptide, Brain; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors | 2002 |
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2002 |
The ALLHAT Trial. Diuretics are still the preferred initial drugs for high blood pressure.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure Determination; Chlorthalidone; Diuretics; Dose-Response Relationship, Drug; Doxazosin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Male; Middle Aged; Patient Compliance; Probability; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2003 |
Are thiazide diuretics preferred as first-line therapy for hypertension? An appraisal of The Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Aged; Amlodipine; Benzothiadiazines; Blood Chemical Analysis; Chlorthalidone; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Myocardial Infarction; Queensland; Reference Values; Risk Assessment; Severity of Illness Index; Sodium Chloride Symporter Inhibitors; Stroke; Survival Analysis; Treatment Outcome | 2003 |
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Lisinopril; Male | 2003 |
Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cough; Female; Humans; Lisinopril; Losartan; Male; Middle Aged; Prospective Studies | 2004 |
Hemodynamic effects of amlodipine, bisoprolol, and lisinopril in hypertensive patients after liver transplantation.
Topics: Adult; Aged; Aldosterone; Amlodipine; Antihypertensive Agents; Bisoprolol; Cross-Over Studies; Female; Humans; Hypertension; Lisinopril; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Renin; Treatment Outcome | 2004 |
Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial).
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Female; Femoral Artery; Humans; Hypertension; Lisinopril; Male; Middle Aged; Tunica Intima; Tunica Media; Ultrasonography | 2004 |
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Incidence; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Patient Compliance; Risk Factors; Treatment Outcome | 2005 |
Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Double-Blind Method; Doxazosin; Female; Follow-Up Studies; Genotype; Humans; Lisinopril; Male; Middle Aged; Peptidyl-Dipeptidase A; Pharmacogenetics; Polymorphism, Genetic; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2005 |
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Glucose; Chlorthalidone; Coronary Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypoglycemia; Lisinopril; Male; Middle Aged; Treatment Outcome | 2005 |
Clinical study on safety and efficacy of the administration of amlodipine in a combination with lisinopril in hypertensive patients.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Humans; Hypertension; Lisinopril | 2005 |
Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
Topics: Aged; Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Chlorthalidone; Chronic Disease; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Risk Factors | 2006 |
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chlorthalidone; Diuretics; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Treatment Outcome | 2006 |
Antihypertensive therapy, the alpha-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calmodulin-Binding Proteins; Chlorthalidone; Coronary Disease; Double-Blind Method; Doxazosin; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glycine; Humans; Hypertension; Incidence; Kaplan-Meier Estimate; Lisinopril; Male; Middle Aged; Patient Selection; Polymorphism, Genetic; Proportional Hazards Models; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Tryptophan | 2007 |
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Topics: Amlodipine; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Black People; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Cardiac Output, Low; Cardiovascular Diseases; Coronary Disease; Female; Gastrointestinal Hemorrhage; Glomerular Filtration Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Hypolipidemic Agents; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Risk; Sex Distribution | 2006 |
[Combined therapy with amlodipin and lisinopril in arterial hypertension: efficacy of a low-dose combination].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Ultrasonography, Doppler | 2006 |
Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Aged; Aged, 80 and over; Amlodipine; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Canada; Cardiovascular Diseases; Chlorthalidone; Female; Humans; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Prognosis; Risk Factors; Time Factors; United States | 2006 |
Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHA
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Chi-Square Distribution; Chlorthalidone; Diabetes Mellitus; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 2006 |
Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2007 |
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Canada; Chlorthalidone; Clonidine; Double-Blind Method; Doxazosin; Female; Heart Diseases; Hispanic or Latino; Humans; Hydralazine; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Puerto Rico; Reserpine; Treatment Outcome; United States; United States Virgin Islands; White People | 2007 |
[The effect of lisinopril and amlodipine treatment on left ventricular hypertrophy in hypertensive patients].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Middle Aged; Ultrasonography | 2006 |
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Black People; Chlorthalidone; Double-Blind Method; Doxazosin; Female; Humans; Hypertension; Lisinopril; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome; White People | 2008 |
Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Chlorthalidone; Cost-Benefit Analysis; Diuretics; Female; Humans; Hypertension; Kaplan-Meier Estimate; Lisinopril; Male; Middle Aged; Myocardial Infarction; Quality-Adjusted Life Years | 2008 |
[Effect of antihypertensive drugs of various pharmacological groups on reaction of arterial pressure under conditions of stree testing. Part II. Value of various strategies of potentiation of systemic vasodilatation].
Topics: Acrylates; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exercise Test; Follow-Up Studies; Humans; Hypertension; Imidazoles; Lisinopril; Middle Aged; Propanolamines; Receptor, Angiotensin, Type 1; Thiophenes; Treatment Outcome; Vasodilation | 2008 |
[Efficacy of combined antihypertensive treatment with amlodipine and lisinopril in metabolic syndrome].
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Insulin; Lisinopril; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome | 2008 |
Effect of antihypertensive treatment on retinal microvascular changes in hypertension.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Lisinopril; Male; Microcirculation; Middle Aged; Retinal Diseases; Retinal Vessels; Treatment Outcome | 2008 |
[Combined antihypertensive and antilipemic therapy as one of the pillars in the poly-pharmacologic preventive strategy for patients with high cardiovascular risk].
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atorvastatin; Biomarkers; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hungary; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Lisinopril; Male; Metabolic Syndrome; Middle Aged; Prevalence; Pyrroles; Risk Factors | 2008 |
Interaction between antihypertensives and NSAIDs in primary care: a controlled trial.
Topics: Acetaminophen; Aged; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Interactions; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Ibuprofen; Lisinopril; Male; Middle Aged; Osteoarthritis; Piroxicam; Prospective Studies | 2008 |
Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Logistic Models; Male; Middle Aged; Treatment Outcome | 2008 |
Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Fibrinogen; Genetic Variation; Genotype; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Middle Aged; Stroke; Treatment Outcome | 2009 |
Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Double-Blind Method; Drug Packaging; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Medication Adherence; Middle Aged; Monitoring, Physiologic; Prospective Studies; Tablets | 2010 |
Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-to-moderate hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Patient Compliance; Placebos; Prospective Studies; Self Care | 2010 |
Lack of effect of short-term treatment with amlodipine and lisinopril on retinal autoregulation in normotensive patients with type 1 diabetes and mild diabetic retinopathy.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Double-Blind Method; Exercise; Female; Homeostasis; Humans; Intraocular Pressure; Lisinopril; Male; Retinal Artery; Tonometry, Ocular; Young Adult | 2011 |
Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Chlorthalidone; Diabetes Mellitus; Diuretics; Double-Blind Method; Epithelial Sodium Channels; Fasting; Female; Humans; Hypertension; Lisinopril; Longitudinal Studies; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Retrospective Studies; Risk Factors; Treatment Outcome | 2010 |
Carotid artery hemodynamics: observing patient-specific changes with amlodipine and lisinopril by using MR imaging computation fluid dynamics.
Topics: Adult; Amlodipine; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Calcium Channel Blockers; Carotid Artery, Common; Cross-Over Studies; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Lisinopril; Magnetic Resonance Imaging; Male; Middle Aged; Placebos; Rheology; Statistics, Nonparametric | 2010 |
Effects of manidipine and its combination with an ACE inhibitor on insulin sensitivity and metabolic, inflammatory and prothrombotic markers in hypertensive patients with metabolic syndrome: the MARCADOR study.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Dihydropyridines; Drug Combinations; Female; Humans; Hypertension; Insulin Resistance; Lisinopril; Male; Metabolic Syndrome; Middle Aged; Nitrobenzenes; Piperazines; Prospective Studies; Spain; Telmisartan | 2011 |
Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Coronary Disease; Doxazosin; Female; Follow-Up Studies; Genetic Association Studies; Genotype; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2012 |
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Chemical Analysis; Cardiovascular Diseases; Chlorthalidone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hyperkalemia; Hypertension; Hypokalemia; Incidence; Kaplan-Meier Estimate; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Risk Assessment; Survival Rate; Treatment Outcome | 2012 |
Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study.
Topics: Aged; Alleles; Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Chlorthalidone; Double-Blind Method; Female; Follow-Up Studies; Genotype; Heart Failure; Humans; Hypertension; Lisinopril; Male; Middle Aged; Nitric Oxide Synthase Type III; Polymorphism, Single Nucleotide; Risk Factors; Stroke | 2012 |
Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.
Topics: Amlodipine; Antihypertensive Agents; Canada; Chlorthalidone; Chronic Disease; Coronary Disease; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hypertension; Hypolipidemic Agents; Incidence; Kaplan-Meier Estimate; Kidney; Kidney Diseases; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models; Puerto Rico; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke; Time Factors; Treatment Outcome; United States; United States Virgin Islands | 2012 |
Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypolipidemic Agents; Incidence; Lisinopril; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Factors; Stroke | 2013 |
[Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Comorbidity; Diabetes Mellitus, Type 2; Drug Combinations; Endothelium, Vascular; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Severity of Illness Index; Time Factors; Treatment Outcome | 2013 |
Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chlorthalidone; Diuretics; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Risk Factors; Treatment Outcome | 2013 |
[Impact of combination antihypertensive therapy on heart rate variability parameters and target organ status in patients with arterial hypertension and type 2 diabetes mellitus].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Comorbidity; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Lisinopril; Male; Middle Aged; Treatment Outcome | 2013 |
Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Topics: Acute Coronary Syndrome; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Calcium Channel Blockers; Chlorthalidone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Office Visits; Prognosis; Risk Factors; Treatment Outcome | 2014 |
Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHAT.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Cohort Studies; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Obesity; Overweight; Prospective Studies | 2014 |
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT.
Topics: Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Kaplan-Meier Estimate; Lisinopril; Male; Middle Aged; Peripheral Arterial Disease; United States | 2014 |
[Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Flow Velocity; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Endothelium, Vascular; Female; Humans; Hypertension; Laser-Doppler Flowmetry; Lisinopril; Male; Microcirculation; Middle Aged; Nitric Oxide; Treatment Outcome; Vasodilation | 2014 |
Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT.
Topics: Age Factors; Aged; Amlodipine; Cause of Death; Chlorthalidone; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Kaplan-Meier Estimate; Lisinopril; Male; Middle Aged; Proportional Hazards Models; Risk Assessment; Severity of Illness Index; Sex Factors; Stroke; Survival Rate; Treatment Outcome | 2014 |
[A fixed-dose lisinopril and amlodipine combination in conjunction with rosuvastatin in patients with hypertensive disease and coronary heart disease].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Coronary Disease; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Dyslipidemias; Essential Hypertension; Female; Fluorobenzenes; Humans; Hypertension; Hypolipidemic Agents; Lipid Metabolism; Lisinopril; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2014 |
[The Antihypertensive Effect of the Fixed Combination of Lisinopril and Amlodipine in Patients With Coronary Heart Disease After Coronary Artery Bypass Grafting].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Male; Middle Aged; Patient Compliance; Postoperative Care; Prospective Studies; Retrospective Studies; Treatment Outcome | 2015 |
[Cardio-Nephroprotection--the Most Important Goal of Antihypertensive Therapy in Patients With Type 2 Diabetes].
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2015 |
Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease.
Topics: Aged; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Electrocardiography; Female; Heart Conduction System; Humans; Lisinopril; Male; Middle Aged; Prognosis | 2016 |
Clinical and demographic correlates of medication and visit adherence in a large randomized controlled trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Appointments and Schedules; Black People; Chlorthalidone; Demography; Double-Blind Method; Female; Humans; Hypertension; Lisinopril; Male; Medication Adherence; Middle Aged; Myocardial Infarction; North America; Patient Compliance; Retrospective Studies; Treatment Outcome | 2016 |
Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Female; Follow-Up Studies; Hip Fractures; Humans; Intention to Treat Analysis; Lisinopril; Male; Pelvic Bones; Risk Assessment; Risk Factors; United States | 2017 |
Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Electrocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Hypolipidemic Agents; Incidence; Lipids; Lisinopril; Male; Middle Aged; Myocardial Infarction; Prevalence; Risk Factors | 2016 |
Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Treatment Failure; Treatment Outcome | 2017 |
Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cause of Death; Chlorthalidone; Disease Progression; Electrocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Topics: Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Doxazosin; Drug Monitoring; Female; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Treatment Outcome | 2017 |
Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Topics: Amlodipine; Antihypertensive Agents; Atrial Fibrillation; Atrial Flutter; Chlorthalidone; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Primary Prevention; Risk Factors; Time Factors; Treatment Outcome; United States | 2017 |
A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYp
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Asian People; Black People; Chlorthalidone; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension; Lisinopril; Middle Aged; Prospective Studies; United Kingdom; White People; Young Adult | 2018 |
Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Atrial Fibrillation; Atrial Flutter; Chlorthalidone; Coronary Disease; Double-Blind Method; Female; Heart Failure; Humans; Hypertension; Lisinopril; Male; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Stroke | 2018 |
The Precision HYpertenSIon Care (PHYSIC) study: a double-blind, randomized, repeated cross-over study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Precision Medicine; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Tetrazoles | 2019 |
The Interaction of a Diabetes Gene Risk Score With 3 Different Antihypertensive Medications for Incident Glucose-level Elevation.
Topics: Alkadienes; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Calcium Channel Blockers; Chlorthalidone; Diabetes Mellitus; Female; Gene Frequency; Genetic Testing; Genotype; Humans; Hypertension; Lisinopril; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Risk Factors; Sodium Chloride Symporter Inhibitors | 2019 |
Treating Hypertension in Children With
Topics: Academic Medical Centers; Adolescent; Amlodipine; Antihypertensive Agents; Bayes Theorem; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Child; Cross-Over Studies; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Patient Preference; Precision Medicine; Texas; Treatment Outcome | 2019 |
Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Causality; Chlorthalidone; Doxazosin; Electrocardiography; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Linear Models; Lisinopril; Logistic Models; Male; Middle Aged; Personal Protective Equipment; Proportional Hazards Models | 2019 |
ANICHKOV study: the effect of combined hypotensive and lipid-lowering therapy on cardiovascular complications in patients of high and very high risk.
Topics: Adolescent; Amlodipine; Anticholesteremic Agents; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Drug Combinations; Humans; Lipids; Lisinopril; Medication Adherence; Moscow; Treatment Outcome | 2019 |
Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium; Calcium Channel Blockers; Chlorthalidone; Diuretics; Double-Blind Method; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Risk Factors; United States | 2021 |
Bioequivalence evaluation and food effect assessment of Lisinopril/amlodipine tablets in healthy Chinese subjects under fasting and fed conditions.
Topics: Amlodipine; China; Chromatography, Liquid; Fasting; Healthy Volunteers; Humans; Lisinopril; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency | 2022 |
Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Precision Medicine | 2023 |
81 other study(ies) available for amlodipine and lisinopril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Protein synthesis in the hypertrophied heart of spontaneously hypertensive rats and a comparison of the effects of an ACE-inhibitor and a calcium channel antagonist.
Topics: Amlodipine; Animals; Blood Pressure; DNA; Heart Ventricles; Hypertrophy, Left Ventricular; Lisinopril; Protein Biosynthesis; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA | 1995 |
Effects of angiotensin converting enzyme inhibition on cardiac collagen in hypertensive and normotensive rats.
Topics: Amlodipine; Animals; Blood Pressure; Collagen; Heart; Hydroxyproline; Hypertension; Lisinopril; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1994 |
The regression of chronic hypertrophy by a calcium channel antagonist and an ACE-inhibitor.
Topics: Amlodipine; Animals; Blood Pressure; Cardiomegaly; Chronic Disease; Lisinopril; Male; Muscle Proteins; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1994 |
Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure.
Topics: Amlodipine; Antihypertensive Agents; Dipeptides; Hemodynamics; Humans; Kidney Failure, Chronic; Lisinopril; Middle Aged; Potassium; Proteinuria; Renal Circulation; Renin; Verapamil | 1993 |
Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
Topics: Adult; Amlodipine; Antihypertensive Agents; Benzeneacetamides; Carbazoles; Carvedilol; Diet, Sodium-Restricted; Diltiazem; Dipeptides; Doxazosin; Exercise; Felodipine; Female; Hemodynamics; Humans; Hypertension; Ketanserin; Labetalol; Lisinopril; Longitudinal Studies; Male; Middle Aged; Propanolamines | 1993 |
Predictive value of ambulatory blood pressure shortly after withdrawal of antihypertensive drugs in primary care patients.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Family Practice; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Male; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity | 1996 |
Nephrotic syndrome after norfloxacin.
Topics: Aged; Amlodipine; Anti-Infective Agents; Antihypertensive Agents; Clonidine; Creatinine; Diuretics; Female; Furosemide; Humans; Indomethacin; Isosorbide Dinitrate; Lisinopril; Nephrotic Syndrome; Norfloxacin; Proteinuria; Urinary Tract Infections | 1996 |
Differential effects of antihypertensive drugs with differing pharmacological properties on the basal ambulatory blood pressure. Japanese Ambulatory Pressure-ANtihypertensive Effects SEarching study group.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; Lisinopril; Male; Middle Aged; Nifedipine; Office Visits; Systole | 1998 |
Effects of lisinopril and amlodipine on antioxidant status in experimental hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Blood Urea Nitrogen; Calcium Channel Blockers; Cholesterol; Hypertension; Lisinopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Serum Albumin; Triglycerides; Vitamin A; Vitamin E | 2000 |
[Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study].
Topics: Adrenergic alpha-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Canada; Chlorthalidone; Coronary Disease; Diuretics; Doxazosin; Humans; Hypertension; Lisinopril; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk; United States | 2000 |
[Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Diuretics; Doxazosin; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Research Design; Treatment Outcome | 2003 |
[ALLHAT--the most comprehensive antihypertensive treatment trial in the world. The significance of thiazide diuretics for patients older than 55 years is confirmed].
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Diuretics; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Sodium Chloride Symporter Inhibitors | 2003 |
[Consequences of ALLHAT: Thiazides rehabilitated--time to change prescription patterns].
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Chlorthalidone; Cost Savings; Diuretics; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors | 2003 |
ALLHAT finds diuretics best for initial hypertension therapy.
Topics: Amlodipine; Antihypertensive Agents; Chlorthalidone; Clinical Trials as Topic; Diuretics; Humans; Hypertension; Lisinopril; Myocardial Infarction | 2003 |
Diuretics: first choice for treating high BP.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Chlorthalidone; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Lisinopril; Middle Aged | 2003 |
[Established blood pressure drug wins out in a comparative study. In hypertension, a diuretic first!].
Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Chlorthalidone; Coronary Disease; Diuretics; Double-Blind Method; Doxazosin; Humans; Hypertension; Lisinopril; Middle Aged; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors | 2003 |
Hats off to an old blood pressure drug. For treating high blood pressure, an old--and inexpensive--medication is a great place to start or a good one to add.
Topics: Amlodipine; Antihypertensive Agents; Chlorthalidone; Clinical Trials as Topic; Diuretics; Humans; Hypertension; Lisinopril | 2003 |
[What are the sequelae of the ALLHAT Study?].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Critical Pathways; Humans; Hypertension; Lisinopril; Randomized Controlled Trials as Topic | 2003 |
Diuretics: older, cheaper, better.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Diuretics; Doxazosin; Humans; Hypertension; Lisinopril; Middle Aged; Sodium Chloride Symporter Inhibitors | 2003 |
[ALLHAT: Old Hat Hits All? On selection of the optimal antihypertensive drug].
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cause of Death; Chlorthalidone; Dose-Response Relationship, Drug; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Long-Term Care; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome | 2003 |
Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Diuretics; Humans; Hypertension; Lisinopril; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; United States | 2003 |
A cheaper way to control high blood pressure.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Diuretics; Humans; Hypertension; Lisinopril | 2003 |
ALLHAT--all hit or all miss? Key questions still remain.
Topics: Amlodipine; Antihypertensive Agents; Black People; Chlorthalidone; Humans; Hypolipidemic Agents; Lisinopril; Myocardial Infarction; Research Design; Survival Analysis; White People | 2003 |
[The new (old) knowledge in primary prevention of stroke. It depends on lowering of blood pressure].
Topics: Adrenergic alpha-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Doxazosin; Follow-Up Studies; Heart Failure; Humans; Lisinopril; Middle Aged; Myocardial Infarction; Primary Prevention; Stroke; Time Factors | 2003 |
ALLHAT: what has it taught us so far?
Topics: Amlodipine; Antihypertensive Agents; Chlorthalidone; Humans; Hypertension; Lisinopril; Myocardial Infarction; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic | 2004 |
[Effect of enalapril, lisinopril, and amlodipine on the course of chronic gastrititis in patients with arterial hypertension].
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Data Interpretation, Statistical; Enalapril; Female; Gastric Mucosa; Gastritis; Humans; Hypertension; Lisinopril; Male; Middle Aged; Time Factors | 2004 |
Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Diuretics; Humans; Hypertension; Lisinopril; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome | 2005 |
Summaries for patients. Do the effects of blood pressure drugs differ by kidney function?
Topics: Aged; Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Chlorthalidone; Chronic Disease; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Risk Factors | 2006 |
Omission of drug dose information.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chlorthalidone; Dose-Response Relationship, Drug; Humans; Hypertension; Lisinopril; Randomized Controlled Trials as Topic | 2006 |
The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
Topics: Adrenergic alpha-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Comorbidity; Double-Blind Method; Doxazosin; Female; Heart Failure; Humans; Hypertension; Lisinopril; Male; Middle Aged; Prognosis; Randomized Controlled Trials as Topic; Research Design; Sodium Chloride Symporter Inhibitors | 2007 |
Blood pressure drugs can boost blood sugar. Depending on the drug, though, it may not matter.
Topics: Amlodipine; Antihypertensive Agents; Blood Glucose; Chlorthalidone; Clinical Trials as Topic; Diabetes Mellitus; Diuretics; Humans; Lisinopril | 2007 |
The putative link between glycemic control and cardiac arrhythmias.
Topics: Amlodipine; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Glucose; Chlorthalidone; Diabetes Mellitus; Diuretics; Humans; Hypertension; Lisinopril | 2007 |
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent
Topics: Aged; Amlodipine; Antihypertensive Agents; Atherosclerosis; Blood Pressure; Chlorthalidone; Cohort Studies; Coronary Disease; Female; Humans; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Risk Factors | 2008 |
Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Diuretics; Doxazosin; Female; Genotype; Humans; Hypertension; Lisinopril; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide | 2008 |
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growt
Topics: Acrylates; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enalapril; Humans; Imidazoles; Indazoles; Lisinopril; Male; Mice; Mice, SCID; Neoplasms; Nifedipine; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Ramipril; Rats; Rats, Sprague-Dawley; Telmisartan; Thiophenes; Xenograft Model Antitumor Assays | 2009 |
[Anti-RNA polymerase III antibodies in scleroderma renal crisis].
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Antinuclear; Benzimidazoles; Biopsy; Biphenyl Compounds; Combined Modality Therapy; Diagnosis, Differential; Humans; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Lisinopril; Male; Plasmapheresis; Renal Dialysis; RNA Polymerase II; Scleroderma, Systemic; Tetrazoles; Thrombotic Microangiopathies; Vasodilator Agents | 2010 |
Strengthening diuretics' role in hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Diuretics; Humans; Hypertension; Lisinopril | 2010 |
Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Case-Control Studies; Endothelium, Vascular; Female; Fibrinolysis; Humans; Hypertension; Irbesartan; Lisinopril; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System; Tetrazoles | 2012 |
Initial choice of antihypertensive on long-term cardiovascular outcomes in CKD.
Topics: Amlodipine; Antihypertensive Agents; Chlorthalidone; Female; Glomerular Filtration Rate; Humans; Hypertension; Hypolipidemic Agents; Kidney; Kidney Diseases; Lisinopril; Male; Myocardial Infarction | 2012 |
[Antihypertensive efficacy of a low-dose combination of amlodipine and lisinopril in the treatment of arterial hypertension in postmenopausal women].
Topics: Amlodipine; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hypertension; Lisinopril; Middle Aged; Postmenopause | 2012 |
[Medical mistakes due to generic substitution].
Topics: Amlodipine; Antihypertensive Agents; Drug Costs; Drug Labeling; Drug Prescriptions; Drug Substitution; Drugs, Generic; Female; Humans; Lisinopril; Medication Errors; Middle Aged; Patient Safety | 2012 |
How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?
Topics: Amlodipine; Antihypertensive Agents; Biostatistics; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Coronary Disease; Endpoint Determination; Heart Failure; Humans; Hypertension; Lisinopril; Myocardial Infarction; Randomized Controlled Trials as Topic; Regression Analysis; Treatment Outcome | 2013 |
[Potentialities of medicinal correction of cerebrovascular disturbances in patients with arterial hypertension].
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Cerebrovascular Disorders; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Lisinopril; Middle Aged; Random Allocation; Severity of Illness Index; Treatment Outcome | 2012 |
Angioedema in a patient with renal cell cancer treated with everolimus in combination with an angiotensin-converting enzyme inhibitor.
Topics: Adrenal Cortex Hormones; Amlodipine; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Antineoplastic Agents; Calcium Channel Blockers; Carcinoma, Renal Cell; Drug Administration Schedule; Drug Interactions; Everolimus; Female; Humans; Kidney Neoplasms; Lisinopril; Middle Aged; Sirolimus; TOR Serine-Threonine Kinases | 2013 |
Venoarterial extracorporeal membrane oxygenation for the management of massive amlodipine overdose.
Topics: Amlodipine; Extracorporeal Membrane Oxygenation; Humans; Hydrochlorothiazide; Lisinopril; Male; Middle Aged; Respiration, Artificial; Respiratory Insufficiency; Treatment Outcome | 2014 |
Commentary in support of a highly effective hypertension treatment algorithm.
Topics: Adult; Algorithms; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Spironolactone; Treatment Outcome; United States | 2013 |
[Results of the Russian EKSPERT program: post-marketing supervision over efficacy and influence of the preparation Ekvator on quality of life at out-patients with arterial hypertension].
Topics: Aged; Ambulatory Care; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Comorbidity; Drug Combinations; Drug Monitoring; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Product Surveillance, Postmarketing; Program Evaluation; Quality of Life; Risk Factors; Russia; Treatment Outcome | 2014 |
Pharmacogenetic effects of 'candidate gene complexes' on stroke in the GenHAT study.
Topics: Aged; Amlodipine; Chlorthalidone; Female; Genotype; Humans; Lisinopril; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Stroke | 2014 |
[24-Hour blood pressure profiles in brachial artery and the aorta: correlation and effects of fixed combination of amlodipine and lisinopril].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Arterial Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Brachial Artery; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Statistics as Topic; Treatment Outcome | 2014 |
A dearth of data: the problem of phosphorus in prescription medications.
Topics: Amlodipine; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Drug Labeling; Drugs, Generic; Humans; Lisinopril; Paroxetine; Phosphorus; Prescription Drugs; Renal Dialysis | 2015 |
[Effect of combination antihypertensive therapy on circadian blood pressure and metabolic parameters in patients with type 2 diabetes mellitus].
Topics: Amlodipine; Antihypertensive Agents; Biological Availability; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Diabetes Mellitus, Type 2; Drug Combinations; Drug Monitoring; Female; Humans; Hypertension; Hypoglycemic Agents; Lipid Metabolism; Lisinopril; Male; Middle Aged; Prospective Studies; Russia; Treatment Outcome | 2014 |
Interaction of PEGylated anti-hypertensive drugs, amlodipine, atenolol and lisinopril with lipid bilayer membrane: A molecular dynamics simulation study.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Diffusion; Dimyristoylphosphatidylcholine; Energy Transfer; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Lisinopril; Molecular Dynamics Simulation; Molecular Structure; Polyethylene Glycols; Software; Static Electricity; Structure-Activity Relationship; Time Factors; Water | 2015 |
[Stiffness of the Arterial Wall and Central Hemodynamics During Long-Term Combination Antihypertensive Therapy].
Topics: Aged; Amlodipine; Antihypertensive Agents; Aorta; Blood Pressure; Drug Combinations; Essential Hypertension; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension; Lisinopril; Male; Middle Aged; Organ Size; Prognosis; Vascular Stiffness; Ventricular Dysfunction, Left | 2015 |
[Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Databases, Factual; Drug Combinations; Female; Humans; Hypertension; Lisinopril; Male; Medication Adherence; Middle Aged; Ramipril; Retrospective Studies | 2016 |
Hypokalaemia and drinking green tea: a literature review and report of 2 cases.
Topics: Aged; Amlodipine; Antihypertensive Agents; Bendroflumethiazide; Drinking Behavior; Female; Humans; Hypertension; Hypokalemia; Lisinopril; Male; Tea | 2016 |
Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.
Topics: Aged; Amlodipine; Antihyperkalemic Agents; Blood Pressure; Blood Pressure Determination; Chlorthalidone; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Treatment Outcome | 2016 |
[Effects of Amlodipine/Lisinopril Fixed-Dose Combination on Severity of Left Ventricular Hypertrophy and Parameters of Myocardial Stiffness in Patients With Hypertension].
Topics: Aged; Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Echocardiography, Doppler; Female; Heart Atria; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Middle Aged; Vascular Stiffness | 2016 |
[Comparative Assessment of Effects of Free and Fixed Combinations of Hypotensive Drugs on Quality of Life of Patients With Arterial Hypertension of High and Very High Risk].
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Female; Humans; Hypertension; Indapamide; Lisinopril; Male; Middle Aged; Quality of Life; Ramipril; Random Allocation; Surveys and Questionnaires | 2016 |
Combination of anti-hypertensive drugs: a molecular dynamics simulation study.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Dimyristoylphosphatidylcholine; Humans; Hydrogen Bonding; Hypertension; Lipid Bilayers; Lisinopril; Molecular Conformation; Molecular Dynamics Simulation; Software; Water | 2017 |
[Lisinopril, Amlodipine, Rosuvastatin as a Novel Fixed Combination in the Fight Against Cardiovascular Disease].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Combinations; Humans; Hypertension; Lisinopril; Rosuvastatin Calcium | 2017 |
Without Warning: Scleroderma Renal Crisis.
Topics: Acute Kidney Injury; Amlodipine; Antihypertensive Agents; Humans; Hypertension; Labetalol; Lisinopril; Male; Nicardipine; Scleroderma, Limited | 2019 |
'Temporary Plasticiser': A novel solution to fabricate 3D printed patient-centred cardiovascular 'Polypill' architectures.
Topics: Amlodipine; Cardiovascular Agents; Cardiovascular Diseases; Chemistry, Pharmaceutical; Crystallization; Drug Carriers; Drug Combinations; Drug Compounding; Drug Delivery Systems; Drug Liberation; Humans; Indapamide; Lisinopril; Plasticizers; Polyvinyl Alcohol; Printing, Three-Dimensional; Rosuvastatin Calcium; Tablets; Technology, Pharmaceutical; Temperature; X-Ray Diffraction | 2019 |
Effects of Different Antihypertensive Drug Combinations on Blood Pressure and Arterial Stiffness.
Topics: Aged; Amlodipine; Antihypertensive Agents; Arteries; Blood Pressure; Diastole; Drug Combinations; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Lisinopril; Losartan; Male; Middle Aged; Prospective Studies; Pulse Wave Analysis; Systole; Valsartan; Vascular Resistance; Vascular Stiffness | 2019 |
Equivalence in Active Pharmaceutical Ingredient of Generic Antihypertensive Medicines Available in Nigeria (EQUIMEDS): A Case for Further Surveillance.
Topics: Amlodipine; Antihypertensive Agents; Drug Compounding; Drugs, Generic; Humans; Lisinopril; Nigeria; Pharmacies; Rural Health; Urban Health | 2019 |
Angioedema secondary to amlodipine and lisinopril: a documented progression.
Topics: Amlodipine; Angioedema; Antihypertensive Agents; Fatal Outcome; Humans; Lisinopril; Male; Middle Aged | 2019 |
Chronic thrombotic microangiopathy secondary to antiphospholipid syndrome, presenting with severe hypertension and chronic renal impairment.
Topics: Adult; Amlodipine; Anticoagulants; Antihypertensive Agents; Antiphospholipid Syndrome; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hypertension; Kidney Diseases; Lisinopril; Thrombotic Microangiopathies; Warfarin | 2019 |
The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Female; Gout; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Treatment Outcome | 2020 |
Non-destructive dose verification of two drugs within 3D printed polyprintlets.
Topics: Amlodipine; Chemistry, Pharmaceutical; Crystallization; Lisinopril; Printing, Three-Dimensional; Quality Control; Spectroscopy, Near-Infrared; Technology, Pharmaceutical; Thermogravimetry; X-Ray Diffraction | 2020 |
Oral Manifestations of Commonly Prescribed Drugs.
Topics: Albuterol; Amlodipine; Anticonvulsants; Antihypertensive Agents; Atorvastatin; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bronchodilator Agents; Deprescriptions; Drug Hypersensitivity; Fluorides; Gingival Overgrowth; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Hypoglycemic Agents; Lisinopril; Losartan; Metformin; Metoprolol; Mouth Diseases; Omeprazole; Oral Hygiene; Proton Pump Inhibitors; Simvastatin; Thyroxine; Toothpastes; Xerostomia | 2020 |
Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin.
Topics: Aged; Amlodipine; Antihypertensive Agents; Anxiety; Blood Pressure; Chronotherapy; Humans; Hypertension; Lisinopril; Metabolic Syndrome; Middle Aged; Rosuvastatin Calcium | 2021 |
Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study.
Topics: Aged; Amlodipine; Blood Pressure; Blood Pressure Determination; Cardiovascular Diseases; Chlorthalidone; Diastole; Female; Follow-Up Studies; Heart Failure; Humans; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Risk Assessment; Risk Factors; Stroke; Systole | 2021 |
Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial.
Topics: Amlodipine; Antihypertensive Agents; Chlorthalidone; Humans; Hypertension; Isolated Systolic Hypertension; Lisinopril; Treatment Outcome | 2022 |
Antihypertensive medicine use differs between Ghana and Nigeria.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Ghana; Humans; Hypertension; Lisinopril; Losartan; Nifedipine; Nigeria | 2022 |
EFFECTIVENESS OF LISINOPRIL AND AMLODIPINE COMBINATION AT HYPERTENSION WITH COMORBIDITY OF ARTERIOSCLEROSIS OBLITERANS IN GENERAL PRACTICE.
Topics: Amlodipine; Antihypertensive Agents; Arteriosclerosis Obliterans; Blood Pressure; Comorbidity; General Practice; Humans; Hypertension; Lisinopril | 2022 |
THE NITROSAMINE CONTAMINATION IN BETA BLOCKERS (BISOPROLOL/METOPROLOL), ACE INHIBITORS (LISINOPRIL/PERINDOPRIL), THIAZIDES DIURETICS (HCT), CALCIUM CHANNEL BLOCKERS (AMLODIPINE/FELODIPINE), SARTANS (CANDESARTAN) AND ТHE SUBSEQUENT SKIN CANCER DEVELOPMENT
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Felodipine; Humans; Lisinopril; Melanoma; Metoprolol; Nitrosamines; Perindopril; Prospective Studies; Skin Neoplasms; Sodium Chloride Symporter Inhibitors; Thiazides | 2023 |